MedPath

Nasr Fascial Closure: A Novel Device for Fascial Closure in Laparoscopic Surgery

Not Applicable
Recruiting
Conditions
Cholecystolithiasis
Registration Number
NCT06036303
Lead Sponsor
ClinAmygate
Brief Summary

The study will investigate the efficacy and safety of a new fascial closure device "Nasr Fascial Closure Device" compared to the Karl Storz Berci Fascial Closure Device 26173AM.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
160
Inclusion Criteria
  • age > 18
  • eligible for Laparoscopic cholecystectomy
Exclusion Criteria
  • refused to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
duration of port site closure1 day

Duration in seconds

Rate of failure of port site1 day

Rate of failure to close the port site

Secondary Outcome Measures
NameTimeMethod
Incidence of port site hernia6 weeks

Incidence of hernia at the port site

Incidence of port site infection1 month

Incidence of infection of the port site

Trial Locations

Locations (1)

Aswan University Hospital

🇪🇬

Aswan, Egypt

Aswan University Hospital
🇪🇬Aswan, Egypt
Mohie El-Din M Madany, MD
Principal Investigator
© Copyright 2025. All Rights Reserved by MedPath